50 results
424B7
BHVN
Biohaven Ltd.
16 Aug 24
Prospectus with selling stockholder info
4:31pm
for new clinical trials, and the timing of clinical trial results;
our plans to pursue research and development of other products;
anticipated future
424B5
BHVN
Biohaven Ltd.
16 Aug 24
Prospectus supplement for primary offering
4:21pm
, and the timing of clinical trial results;
our plans to pursue research and development of other products;
anticipated future milestones, contingent … , commencement dates for new clinical trials, and the timing of clinical trial results;
our plans to pursue research and development of other products
8-K
EX-99.1
BHVN
Biohaven Ltd.
8 Aug 24
Biohaven Reports Second Quarter 2024 Financial Results and Recent Business Developments
4:17pm
expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income, net
Loss before provision … , marketable securities and restricted cash totaled approximately $440 million on June 30, 2024.
Second Quarter 2024 Financial Highlights:
Research
424B7
BHVN
Biohaven Ltd.
17 May 24
Prospectus with selling stockholder info
4:41pm
, and the timing of clinical trial results;
our plans to pursue research and development of other products;
anticipated future milestones, contingent
8-K
EX-99.1
1ryxe
9 May 24
Biohaven Reports First Quarter 2024 Financial Results and Recent Business Developments
4:14pm
424B5
mu5d55d
19 Apr 24
Prospectus supplement for primary offering
6:02am
424B5
36zxx8 0jhjp8z
17 Apr 24
Prospectus supplement for primary offering
4:01pm
424B7
6l8z0pnw641jrw71p0
12 Mar 24
Prospectus with selling stockholder info
4:37pm
8-K
EX-99.1
661kx13d8b
29 Feb 24
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
4:16pm
8-K
EX-99.1
116q d6x3akkc7v8s
14 Nov 23
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
4:26pm
424B5
ztj trxvp
4 Oct 23
Prospectus supplement for primary offering
4:05pm
424B5
m8g715l
2 Oct 23
Prospectus supplement for primary offering
5:09pm
424B5
83g52th1
2 Oct 23
Prospectus supplement for primary offering
5:07pm
S-3ASR
vhg6vo1
2 Oct 23
Automatic shelf registration
4:01pm